About: Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 13 May 2013

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2013 (uk) im Mai 2013 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 13 May 2013 (en) artículu científicu espublizáu en mayu de 2013 (ast)
publication date	wds:Q86766498-053FA438-F5FE-450F-B89D-98367F998D56
publication date	2013-05-13 00:00:00Z (xsd:dateTime)
exact match	wds:Q86766498-AD250007-85DA-4F82-BF38-049B6026850F
exact match	https://scigraph.springernature.com/pub.10.1038/bmt.2013.68
cites work	wds:Q86766498-01435C50-6CE7-4D4F-9E8B-05E7DC5D92D8 wds:Q86766498-111716D3-D769-42A1-98C4-53F1D48F17D1 wds:Q86766498-2E43D9BE-44BD-4ADC-930B-6FB40E4F3770 wds:Q86766498-38D9EA8E-1D00-4516-8A52-4DC77AD200ED wds:Q86766498-38FD246C-DC0A-4CE9-A0CF-03915110BEB7 wds:Q86766498-3D913533-6CE6-427C-8F9A-EEADEE57CC2E wds:Q86766498-3DDA6787-7BA5-4214-B9F1-B5EB90D8C8EA wds:Q86766498-4001324A-55B2-460D-9F11-5735110B1699 wds:Q86766498-50B93DF9-C130-4D3F-AA99-7629A4931403 wds:Q86766498-5490068D-3062-4B96-81D9-FAE8A4EDB363 wds:Q86766498-6255FEA3-0F9D-422C-A5B3-6F2D8D4C8401 wds:Q86766498-6FE6D568-FD08-4156-957F-C8FA1C0979BC wds:Q86766498-744874A8-69D6-48B3-80FF-5EEFB0EC1DAA wds:Q86766498-758935FA-5D26-4348-A206-B08DCF65B9F3 wds:Q86766498-77F84980-2CC8-4179-9087-1C1FECAAEA0F wds:Q86766498-791F96A4-B4C1-493F-9D83-8C2B31FD7FFB wds:Q86766498-87361F23-52F3-4CA6-8F25-FF1133F5D6AA wds:Q86766498-8EA6FE37-1E25-4A9C-A262-E289A8E32822 wds:Q86766498-90611182-8D2A-4055-84E0-ED2F40A75E1C wds:Q86766498-956801A0-D93E-490E-BCFC-41960BE14311 wds:Q86766498-C2915C99-23FE-45C7-9049-68D9DECBDD8B wds:Q86766498-C9F531CC-7919-432B-83BF-89485D6DFA6D wds:Q86766498-E359873E-BC8E-41B0-8217-80D2672F99AB wds:Q86766498-EA60E543-4817-4900-AD13-4F75BDEF9AE8 wds:Q86766498-F68C55FD-D04F-4B70-854E-EBEE662BD0AB wds:Q86766498-FE980AB3-E4A1-4588-8D47-7D9FC3BBDE3A
cites work	Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study. The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine. Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation. Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome. Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Rese Efficacy of etoposide, cyclophosphamide, and total body irradiation in allogeneic bone marrow transplantation for adult patients with hematological malignancies
author name string	wds:Q86766498-16075FA0-C83E-4E4A-AC9A-D82A168AB05A wds:Q86766498-1811C1C6-8FE8-4BFF-9F6E-6DA33C7953FB wds:Q86766498-23EB630F-C936-492A-A9D2-3BCB28CFF862 wds:Q86766498-45E823F1-3826-4346-AE9F-7E468C572C16 wds:Q86766498-7FDA1732-6616-4958-8649-74AA824E52DA wds:Q86766498-8E30F017-6755-453D-A30D-2EEFD44A02F2 wds:Q86766498-99178D30-61CE-4D7D-BE20-416240576427 wds:Q86766498-9CBBEB25-AAD0-4B93-A835-349E453FD8FC wds:Q86766498-BDE9C11C-3272-45E6-A42E-7E6C43711560 wds:Q86766498-D9D94B08-5764-48AC-8C1E-A7DED4938469 wds:Q86766498-E3FCB5E0-2E52-4494-8598-070EEEA06065 wds:Q86766498-E41FA4B5-7802-456B-A081-13805273C629 wds:Q86766498-F4CC8F13-326E-460F-B54D-5276C3A3F1FE
author name string	K Ohashi K Kato Y Morishima J Tanaka H Sakamaki N Nishimoto S Taniguchi H Kanamori K Miyamura T Eto S Nishiwaki H Nakamae K Minagawa
rdfs:label	Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) (en) Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) (nl)
skos:prefLabel	Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) (en) Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) (nl)
name	Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) (en) Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) (nl)
author	wds:Q86766498-8BFEF583-AB70-4556-A315-23EC4C4216AE wds:Q86766498-DA318141-F886-4418-B0C7-0139A57B3144 wds:Q86766498-F6C6CFA4-547D-4709-A2F4-83736CF391C3
author	Ritsuro Suzuki Koji Oba Nobuo Masauzi

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software